openPR Logo
Press release

Exclusive interview from conference speaker Dr Sigbjorn Gregusson released ahead of SMi’s 9th Annual Biobanking Conference

07-29-2019 05:27 PM CET | Health & Medicine

Press release from: SMi Group

Biobanking 2019

Biobanking 2019

SMi Reports: SMi has released an exclusive interview with industry expert Dr Sigbjorn Gregusson, Managing Director, BioBank AS ahead of the upcoming Biobanking conference this September

SMi’s 9th Annual Biobanking conference, taking place on 25th-26th September in London, will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications.

During the run-up to the 2019 conference, SMi interviewed industry expert and conference speaker Dr Sigbjorn Gregusson, Managing Director, BioBank AS. Here is a snapshot of what was discussed:

What key differences have you noticed in the last year regarding significant developments in Biobanking?
“Based on BioBank AS's business as an animal biobank and with commercial breeding companies as customers: Our services now support a genotype-based breeding including breeding calculation, developed from a previous phenotype-based breeding regime. The genotyping has changed from testing on some single traits to gene profiles and sequencing, and the extent of genomic selection has increased tremendously. Based on the number of DNA extractions, our work volume has increased by about 6000% if we compare 2019 against 2009, i.e. a time span of just 10 years.”

What current hot topic will you be addressing in your presentation and what would you say makes it relevant to 2019?
“The presentation will mainly be retrospective and tell about the development BioBank AS has been through. In this way, it will be more cold cases than hot topics. However, as of 2019, we will highlight our efforts to extract cell samples from fertilized blastula eggs from cattle, then recover DNA from 7-10 cells and purify and amplify this so that the material can be used for ordinary genetic tests and genomic selection. This work is still experimental, and we truly work within a forensic scale.”

Where do you think the biggest growth area will be for biobanking in the next five years?
“Our market cowers applied genetic to animals, both for commercial breeding (plants, production animals and fish) and for hobby animals and pets. From our perspective, we expect the highest growth in the last segment and we offer now, together with partners, a complete package of storage/ registration of samples, DNA extraction and gene testing for identification/ kinship control, tests for diseases and defects, and in the long term we additional are developing breeding indexes for e.g. use service or hunting dogs”

The full version of the interview and event brochure are available to download online at www.biobanking-event.com/openpr5

Dr Sigbjorn Gregusson will be presenting on “A Case Study of Biobank as a Biorepository Focused on Non-Human Biosamples”
• Our definition of a biobank: BioBank AS as a tool for breeding animals, fish and plants
• Our market: BioBank’s customer structure
• Our journey over the past 10 years: Development in livestock farming from phenotype to genomic selection
• Our challenges: Focus on core business and the value of cooperating partners
• Our success: Commercial operation, competence-intensive small-scale business

Biobanking 2019
Main Conference: 25th - 26th September 2019
Pre-Conference Workshops: 24th September 2019
Location: Copthorne Tara Hotel, London, UK

Proudly sponsored by: Topa and Interactive Software

For sponsorship enquiries please contact Alia Malick on +44 (0)20 7827 6168.

For delegate enquiries contact Kieran Ronaldson on +44 (0)20 7827 6744.

For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk

India House, 45 Curlew Street, London, SE1 2ND

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exclusive interview from conference speaker Dr Sigbjorn Gregusson released ahead of SMi’s 9th Annual Biobanking Conference here

News-ID: 1813805 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Biobank

Global Biobank Market : Trending factors & Growth Drivers Impact Globally
The global biobank market size was USD 76.31 Billion in 2022 and is expected to register a revenue CAGR of 8.8% during the forecast period. The global biobank market is witnessing strong revenue growth, fueled by increasing funding in genomic research, rising demand for personalized medicine, and rapid technological advancements. Biobanks, which store and manage biological samples such as blood, cells, and tissues, play a critical role in therapeutic research,
US biobank Market Size To Boom with Top Key Players 2032 | Penn Medicine BioBank …
The qualitative latest Research report (2025-2032) on the US biobank Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/135012 Focused on growth and
Biobank Sample Management And Storage System Market Size Analysis by Application …
USA, New Jersey- According to Market Research Intellect, the global Biobank Sample Management And Storage System market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The growing need for biobanking solutions in the research and healthcare sectors is driving significant expansion in the market for biobank
Biobanking Market Growth Strategies and Insights, Business Perspectives 2022-202 …
The global biobanking market is poised to grow by USD 18 billion during 2022-2028, progressing at a CAGR of 4.5% during the forecast period. Biobanking Market 2022 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state
Cryopreservation Equipment Market is expected to reach US$ 11,255.02 Mn With CAG …
According to our latest market research study on “Cryopreservation Equipment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type and Application,” the market is expected to reach US$ 11,255.02 million by 2028 from US$ 5,798.82 million in 2021; it is estimated to grow at a CAGR of 9.9% from 2021 to 2028. The report highlights the market trends, drivers, and deterrents. Growing acceptance for
Biobank Market || Opportunity and Industry Revenue Analysis
Prophecy Market Insights has recently published the Biobank informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Biobank market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities